Moderna to acquire Japanese biotech firm OriCiro Genomics for $85m
Moderna has agreed to acquire OriCiro Genomics, a Japanese biotech firm involved in developing cell-free synthesis and amplification of plasmid DNAs for applications in gene or cell-based therapies and synthetic biology. The consideration to be paid by the American biotech company for the acquisition is $85 million. Moderna believes that the synthetic biology and enzyme […]